Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart drug
Biotech
CeleCor's emergency heart attack med wins in key phase 3 trial
CeleCor presented the results of its pivotal CeleBrate phase 3 trial at the the American Heart Association’s annual scientific sessions.
Zoey Becker
Nov 11, 2025 4:45am
Heart drug sheds light on potential pancreatic cancer therapy
Jan 2, 2024 6:30am
Windtree's shock med rapidly raises blood pressure—and shares
Apr 20, 2022 10:38am
Bristol Myers drug helps patients avoid heart procedures
Apr 2, 2022 9:30am
AstraZeneca, Ionis ink $2.9B biobucks deal for heart drug
Dec 29, 2021 10:03am
BridgeBio CEO calls phase 3 failure of heart drug 'baffling'
Dec 28, 2021 8:35am
